Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

October 4, 2017

Proactive Monitoring of Remicade Levels in IBD Patients May Decrease Risk of Hospitalization, Study Finds

News

Proactive monitoring of the levels of Remicade (infliximab) in patients with inflammatory bowel disease (IBD) may help promote patients’ health and decrease their hospital visits, according to scientists from the Center ... Read more

October 3, 2017

Seres’ SER-287 for UC Shows Positive Results in Phase 1b Trial

News

Seres Therapeutics announced positive topline results from the company’s Phase 1b placebo-controlled study investigating the effects of SER-287, a potential microbiome therapy, in patients with ulcerative colitis (UC) who failed ... Read more

September 27, 2017September 27, 2017

Mesenchymal Stem Cell Infusion a Possible Therapy for Crohn’s Fistulas, Review Study Suggests

News

While current treatments for fistulas in Crohn’s disease patients have often led to unsatisfactory results, new stem cell-based therapies, specifically mesenchymal stem cells (MSCs), have shown great potential, a review analysis has ... Read more

September 20, 2017

Mount Sinai Scientists Develop First Predictive Model of Inflammatory Bowel Disease

News

Using information from patient records at different stages of inflammatory bowel disease, New York scientists have developed the world’s first gene-based predictive model of the disorder. An article on the ... Read more

September 5, 2017September 5, 2017

Asthma Identified As Potential Risk Factor for IBD, Canadian Study Suggests

News

Asthma increases the risk for Crohn’s disease and early- and late-onset ulcerative colitis, a Canadian population-based study suggests. The study, “Asthma Is Associated With Subsequent Development of Inflammatory Bowel Disease: A ... Read more

August 28, 2017August 28, 2017

Exclusive Enteral Nutrition Induces Remission in Crohn’s Disease As Effectively as Corticosteroids, Study Finds

News

Exclusive enteral nutrition (EEN) is just as effective as corticosteroids in inducing remission in Crohn’s disease patients — including children — and with fewer adverse effects. According to a review analysis, ... Read more

August 17, 2017August 18, 2017

Measuring Fecal Calprotectin Improves IBD Diagnosis in Children, Study Shows

Crohn's Disease, News

Researchers have found the fecal calprotectin test improves correct diagnosis of inflammatory bowel disease (IBD) in children, and is even more effective than blood test markers. The study, “Use of Laboratory Markers ... Read more

August 11, 2017August 16, 2017

Ulcerative Colitis Investigational Therapy TD-1473 Shows Encouraging Results in Early Trial

News, Ulcerative colitis

Early data from a Phase 1b clinical trial show that the investigational therapy TD-1473 for patients with ulcerative colitis (UC) has demonstrated targeted action and effectiveness, according to the therapy’s ... Read more

August 11, 2017August 21, 2017

Drop in Levels of Specific Enzyme Seen to Favor Development of Pro-Inflammatory T-Cells

Crohn's Disease, News

Low levels of the enzyme PTPN2 promote the development a group of T-cells with pro-inflammatory properties, contributing to syndromes such as Crohn’s disease, scientists report. Their findings suggest that treatments targeting PTPN2 may help ... Read more

August 3, 2017August 18, 2017

University of Arizona Obtains $1.9 Million U.S. Government Grant To Study Key Protein’s Role in Bowel Disease

Crohn's Disease, News

University of Arizona scientists have received a $1.9 million U.S. government grant to study how a protein helps maintain a healthy mix of gut bacteria, and how interfering with the ... Read more